AEMD PE Ratio & Valuation,Is AEMD Overvalued

AEMD Relative Valuation

AEMD's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, AEMD is overvalued; if below, it's undervalued.

Historical Valuation

Aethlon Medical Inc (AEMD) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -2.24. The fair price of Aethlon Medical Inc (AEMD) is between NaN to NaN according to relative valuation methord.

Relative Value

Fair Zone

NaN-NaN

Current Price：3.40

Fair

-0.47

0.00

EV/EBITDA

Aethlon Medical Inc. (AEMD) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is -0.24. The thresholds are as follows: Strongly Undervalued below -1.77, Undervalued between -1.77 and -1.01, Fairly Valued between 0.53 and -1.01, Overvalued between 0.53 and 1.29, and Strongly Overvalued above 1.29. The current Forward EV/EBITDA of 0.00 falls within the Historic Trend Line -Fairly Valued range.

0.21

EV/EBIT

Aethlon Medical Inc. (AEMD) has a current EV/EBIT of 0.21. The 5-year average EV/EBIT is -0.23. The thresholds are as follows: Strongly Undervalued below -4.10, Undervalued between -4.10 and -2.16, Fairly Valued between 1.70 and -2.16, Overvalued between 1.70 and 3.64, and Strongly Overvalued above 3.64. The current Forward EV/EBIT of 0.21 falls within the Historic Trend Line -Fairly Valued range.

0.00

Aethlon Medical Inc. (AEMD) has a current PS of 0.00. The 5-year average PS is 13.63. The thresholds are as follows: Strongly Undervalued below -28.58, Undervalued between -28.58 and -7.48, Fairly Valued between 34.73 and -7.48, Overvalued between 34.73 and 55.83, and Strongly Overvalued above 55.83. The current Forward PS of 0.00 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/OCF

Aethlon Medical Inc. (AEMD) has a current P/OCF of 0.00. The 5-year average P/OCF is -0.72. The thresholds are as follows: Strongly Undervalued below -9.33, Undervalued between -9.33 and -5.02, Fairly Valued between 3.58 and -5.02, Overvalued between 3.58 and 7.88, and Strongly Overvalued above 7.88. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/FCF

Aethlon Medical Inc. (AEMD) has a current P/FCF of 0.00. The 5-year average P/FCF is -0.46. The thresholds are as follows: Strongly Undervalued below -8.49, Undervalued between -8.49 and -4.47, Fairly Valued between 3.55 and -4.47, Overvalued between 3.55 and 7.57, and Strongly Overvalued above 7.57. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

Aethlon Medical Inc (AEMD) has a current Price-to-Book (P/B) ratio of 0.45. Compared to its 3-year average P/B ratio of 0.74 , the current P/B ratio is approximately -39.76% higher. Relative to its 5-year average P/B ratio of 1.19, the current P/B ratio is about -62.42% higher. Aethlon Medical Inc (AEMD) has a Forward Free Cash Flow (FCF) yield of approximately -272.63%. Compared to its 3-year average FCF yield of -181.80%, the current FCF yield is approximately 49.96% lower. Relative to its 5-year average FCF yield of -124.95% , the current FCF yield is about 118.20% lower.

0.45

P/B

Median3y

0.74

Median5y

1.19

-272.63

FCF Yield

Median3y

-181.80

Median5y

-124.95

Competitors Valuation Multiple

The average P/S ratio for AEMD's competitors is 0.35, providing a benchmark for relative valuation. Aethlon Medical Inc Corp (AEMD) exhibits a P/S ratio of 0.00, which is -100% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap

Performance Decomposition

Market capitalization of AEMD increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00%to the performance.

Overall, the performance of AEMD in the past 1 year is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is Aethlon Medical Inc (AEMD) currently overvalued or undervalued?

What is Aethlon Medical Inc (AEMD) fair value?

AEMD's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Aethlon Medical Inc (AEMD) is between NaN to NaN according to relative valuation methord.

How does AEMD's valuation metrics compare to the industry average?

The average P/S ratio for AEMD's competitors is 0.35, providing a benchmark for relative valuation. Aethlon Medical Inc Corp (AEMD) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

What is the current P/B ratio for Aethlon Medical Inc (AEMD) as of Dec 15 2025?

As of Dec 15 2025, Aethlon Medical Inc (AEMD) has a P/B ratio of 0.45. This indicates that the market values AEMD at 0.45 times its book value.

What is the current FCF Yield for Aethlon Medical Inc (AEMD) as of Dec 15 2025?

As of Dec 15 2025, Aethlon Medical Inc (AEMD) has a FCF Yield of -272.63%. This means that for every dollar of Aethlon Medical Inc’s market capitalization, the company generates -272.63 cents in free cash flow.

What is the current Forward P/E ratio for Aethlon Medical Inc (AEMD) as of Dec 15 2025?

As of Dec 15 2025, Aethlon Medical Inc (AEMD) has a Forward P/E ratio of -0.47. This means the market is willing to pay $-0.47 for every dollar of Aethlon Medical Inc’s expected earnings over the next 12 months.

What is the current Forward P/S ratio for Aethlon Medical Inc (AEMD) as of Dec 15 2025?

As of Dec 15 2025, Aethlon Medical Inc (AEMD) has a Forward P/S ratio of 0.00. This means the market is valuing AEMD at $0.00 for every dollar of expected revenue over the next 12 months.

AEMD Valuation

AEMD Valuation

AEMD Relative Valuation

Historical Valuation

Competitors Valuation Multiple

Performance Decomposition

People Also Watch

Frequently Asked Questions

Is Aethlon Medical Inc (AEMD) currently overvalued or undervalued?

What is Aethlon Medical Inc (AEMD) fair value?

How does AEMD's valuation metrics compare to the industry average?

What is the current P/B ratio for Aethlon Medical Inc (AEMD) as of Dec 15 2025?

What is the current FCF Yield for Aethlon Medical Inc (AEMD) as of Dec 15 2025?

What is the current Forward P/E ratio for Aethlon Medical Inc (AEMD) as of Dec 15 2025?

What is the current Forward P/S ratio for Aethlon Medical Inc (AEMD) as of Dec 15 2025?